(Q44909476)

7 December 2017

title

Cardiovascular Dysfunction in Sepsis and Septic Shock (English)

1 reference

7 December 2017

0 references

1 reference

Landgarten MJ

1

1 reference

7 December 2017

Kumar A

series ordinal

2

1 reference

7 December 2017

Parrillo JE

series ordinal

3

1 reference

7 December 2017

publication date

1 October 2000

1 reference

Current treatment options in cardiovascular medicine

7 December 2017

published in

1 reference

7 December 2017

volume

2

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

451-459

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-000-0040-z

7 December 2017

exact match

0 references

cites work

Profound but reversible myocardial depression in patients with septic shock

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-000-0040-Z

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

21 January 2018

1 reference

12 December 2020

Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock

1 reference

12 December 2020

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

1 reference

12 December 2020

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

An Assessment of Myocardial Function in Human Sepsis Utilizing ECG Gated Cardiac Scintigraphy

1 reference

12 December 2020

The coronary circulation in human septic shock

1 reference

12 December 2020

Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.

1 reference

12 December 2020

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

1 reference

12 December 2020

Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility.

1 reference

12 December 2020

Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock

1 reference

12 December 2020

10.1007/S11936-000-0040-Z

Identifiers

DOI

1 reference

7 December 2017

1 reference